SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-18-008127
Filing Date
2018-12-21
Accepted
2018-12-21 18:16:24
Documents
1
Period of Report
2018-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9024
  Complete submission text file 0000919574-18-008127.txt   11607
Mailing Address C/O CAXTON ASSOCIATES 500 PARK AVENUE NEW YORK NY 10022
Business Address
Kovner Bruce (Reporting) CIK: 0001325713 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 181250827

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Reporting) CIK: 0001388551 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 181250828

Mailing Address C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BUILDING #2 PRINCETON NJ 08540
Business Address C/O CAXTON CORPORATION 731 ALEXANDER ROAD, BUILDING #2 PRINCETON NJ 08540 609-419-1800
CDK ASSOCIATES, L.L.C. (Reporting) CIK: 0001576081 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 181250829

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences